Dimensional Fund Advisors LP raised its position in shares of DENTSPLY SIRONA Inc. (NASDAQ:XRAY) by 6.9% in the third quarter, according to the company in its most recent filing with the SEC. The institutional investor owned 1,216,170 shares of the medical instruments supplier’s stock after purchasing an additional 78,454 shares during the quarter. Dimensional Fund Advisors LP owned 0.53% of DENTSPLY SIRONA worth $72,733,000 at the end of the most recent quarter.
A number of other large investors have also recently added to or reduced their stakes in XRAY. Bessemer Group Inc. increased its stake in DENTSPLY SIRONA by 4,638.6% during the 3rd quarter. Bessemer Group Inc. now owns 1,903,596 shares of the medical instruments supplier’s stock valued at $113,855,000 after purchasing an additional 1,863,424 shares in the last quarter. Principal Financial Group Inc. grew its stake in shares of DENTSPLY SIRONA by 22.3% in the second quarter. Principal Financial Group Inc. now owns 6,474,432 shares of the medical instruments supplier’s stock worth $419,802,000 after acquiring an additional 1,181,547 shares during the period. Parnassus Investments CA grew its stake in shares of DENTSPLY SIRONA by 62.7% in the third quarter. Parnassus Investments CA now owns 2,115,000 shares of the medical instruments supplier’s stock worth $126,498,000 after acquiring an additional 815,000 shares during the period. Balyasny Asset Management LLC grew its stake in shares of DENTSPLY SIRONA by 415.5% in the second quarter. Balyasny Asset Management LLC now owns 800,937 shares of the medical instruments supplier’s stock worth $51,933,000 after acquiring an additional 645,564 shares during the period. Finally, Vanguard Group Inc. grew its stake in shares of DENTSPLY SIRONA by 2.5% in the second quarter. Vanguard Group Inc. now owns 22,728,062 shares of the medical instruments supplier’s stock worth $1,473,688,000 after acquiring an additional 562,993 shares during the period. Institutional investors and hedge funds own 96.14% of the company’s stock.
DENTSPLY SIRONA Inc. (NASDAQ:XRAY) opened at $66.26 on Wednesday. The company has a quick ratio of 1.59, a current ratio of 2.32 and a debt-to-equity ratio of 0.21. The stock has a market cap of $15,300.00, a P/E ratio of -19.04, a P/E/G ratio of 2.64 and a beta of 1.31. DENTSPLY SIRONA Inc. has a 1-year low of $52.53 and a 1-year high of $68.98.
The firm also recently disclosed a quarterly dividend, which will be paid on Friday, January 12th. Investors of record on Friday, December 29th will be issued a $0.0875 dividend. This represents a $0.35 dividend on an annualized basis and a dividend yield of 0.53%. The ex-dividend date of this dividend is Thursday, December 28th. DENTSPLY SIRONA’s payout ratio is -10.06%.
In other news, CFO Nicholas W. Alexos purchased 50,000 shares of the stock in a transaction on Monday, November 13th. The shares were acquired at an average price of $65.85 per share, with a total value of $3,292,500.00. The acquisition was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this link. Also, insider Mark Thierer purchased 77,000 shares of the stock in a transaction on Monday, November 13th. The shares were purchased at an average cost of $66.04 per share, for a total transaction of $5,085,080.00. The disclosure for this purchase can be found here. Company insiders own 1.99% of the company’s stock.
XRAY has been the subject of a number of research analyst reports. Deutsche Bank initiated coverage on shares of DENTSPLY SIRONA in a research note on Friday, December 8th. They issued a “buy” rating and a $81.00 price target for the company. Zacks Investment Research upgraded shares of DENTSPLY SIRONA from a “sell” rating to a “hold” rating in a research note on Friday, October 20th. BidaskClub lowered shares of DENTSPLY SIRONA from a “strong-buy” rating to a “buy” rating in a research note on Saturday, December 2nd. Cleveland Research lowered shares of DENTSPLY SIRONA from a “buy” rating to a “neutral” rating in a research note on Thursday, October 5th. Finally, Barrington Research upgraded shares of DENTSPLY SIRONA from a “market perform” rating to an “outperform” rating and set a $73.00 price target for the company in a research note on Monday, November 6th. Two investment analysts have rated the stock with a sell rating, three have given a hold rating and ten have assigned a buy rating to the company’s stock. The company presently has an average rating of “Buy” and an average target price of $69.31.
COPYRIGHT VIOLATION NOTICE: “Dimensional Fund Advisors LP Has $72.73 Million Holdings in DENTSPLY SIRONA Inc. (XRAY)” was posted by Community Financial News and is owned by of Community Financial News. If you are viewing this article on another site, it was copied illegally and republished in violation of US & international trademark and copyright law. The correct version of this article can be viewed at https://www.com-unik.info/2017/12/27/dimensional-fund-advisors-lp-has-72-73-million-holdings-in-dentsply-sirona-inc-xray.html.
DENTSPLY SIRONA Company Profile
DENTSPLY SIRONA Inc is a manufacturer of professional dental products and technologies. The Company develops, manufactures, and markets solutions offering, including dental and oral health products, as well as other consumable medical devices. It operates through two segments: Dental and Healthcare Consumables, and Technologies.
What are top analysts saying about DENTSPLY SIRONA? - Enter your email address in the form below to receive our free daily email newsletter that contains the latest headlines and analysts' recommendations for for DENTSPLY SIRONA and related companies.